Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v5-EN
Language French English
Date Updated 2018-01-30 2018-01-02
Drug Identification Number 02084279 02084279
Brand name NEURONTIN CAP 300MG NEURONTIN CAP 300MG
Common or Proper name NEURONTIN NEURONTIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100's 100's
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-02 2018-01-02
Estimated end date 2018-01-15
Actual end date 2018-01-29
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments